The 3 DailyMed-Approved Retatrutide Injection Sites The DailyMed prescribing label for the Retatrutide Pen states: "Recommended injection sites: abdomen, thigh, or upper arm
Clinical studies have shown that with tirzepatide treatment, patients often lose 15 to 20 percent of their body weight over 72 weeks
This can be a total game-changer, especially if emotional or habitual eating has been a hurdle for you
It often improves or helps prevent obesity-related diseases, including type 2 diabetes, sleep apnea, high blood pressure, and fatty liver disease
Major players such as Novo Nordisk and Eli Lilly have concentrated their marketing and clinical efforts in North America, and high healthcare spending levels ensure a broad customer base